GNH USA

Europe — EMA

Lamivudina + Zidovudina Mylan

GNH USA supplies Lamivudina + Zidovudina Mylan (Zidovudine/Lamivudine), a nucleoside reverse transcriptase inhibitor for HIV-1 infection treatment.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Zidovudine/Lamivudine, the active ingredient in Lamivudina + Zidovudina Mylan, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as a tablet for oral use. It treats HIV-1 infection in adults and children as part of combination antiretroviral therapy.

GNH USA supplies Lamivudina + Zidovudina Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudine/Zidovudine is used in the management of HIV infection, targeting the viral replication pathway.

- HIV-1 infection: reduces plasma viral load when combined with other antiretrovirals. - Mother‑to‑child transmission prophylaxis: lowers the risk of vertical HIV transmission when given to pregnant women. - Treatment‑experienced patients: provides an additional NRTI option within combination regimens.

What are the side effects of Zidovudine, Lamivudine?

Lamivudine/Zidovudine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Headache - Diarrhea - Fatigue

Serious or Rare Side Effects: - Severe neutropenia or anemia - Lactic acidosis and hepatic steatosis - Hypersensitivity reactions including rash or Stevens‑Johnson syndrome

What precautions apply to Zidovudine, Lamivudine?

Before initiating therapy, clinicians should assess baseline laboratory values and monitor patients regularly.

- Hematologic monitoring: check complete blood count for anemia or neutropenia. - Liver function: assess hepatic enzymes and bilirubin periodically. - Renal function: evaluate creatinine clearance in patients with kidney impairment. - Hypersensitivity: discontinue if severe rash or systemic allergic reaction occurs. - Pregnancy and lactation: weigh benefits against potential risks; consult specialist. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Zidovudine, Lamivudine interact with?

Lamivudine/Zidovudine can interact with several antiretroviral and non‑antiretroviral agents.

Major Interactions (Avoid): - Didanosine: concurrent use increases risk of pancreatitis. - Stavudine: combined use may enhance mitochondrial toxicity. - Other NRTIs at high dose: additive bone‑marrow suppression.

Moderate Interactions (Monitor Closely): - Protease inhibitors (e.g., ritonavir): may alter plasma concentrations of zidovudine. - Non‑nucleoside reverse transcriptase inhibitors (e.g., efavirenz): monitor for reduced efficacy. - Warfarin: monitor INR as zidovudine may affect anticoagulant effect.

Frequently asked questions

What is Lamivudina + Zidovudina Mylan used for?+
Lamivudina + Zidovudina Mylan contains zidovudine and lamivudine, two nucleoside reverse transcriptase inhibitors. It is prescribed as part of combination antiretroviral therapy to treat HIV‑1 infection in adults and children, to reduce viral load, and to help prevent mother‑to‑child transmission of HIV.
How does zidovudine/lamivudine work?+
Both drugs are nucleoside analogues that are converted inside cells to active triphosphate forms. These active metabolites compete with natural nucleosides for incorporation into the viral DNA chain by HIV reverse transcriptase, causing premature chain termination and blocking viral replication.
What is the usual dose of Lamivudina + Zidovudina Mylan?+
The exact dose and dosing schedule are determined by the prescribing clinician based on the patient’s age, weight, renal function, and the overall antiretroviral regimen. Healthcare providers follow national and WHO guidelines to individualise therapy.
Is Lamivudina + Zidovudina Mylan safe during pregnancy or breastfeeding?+
Safety in pregnancy and lactation has not been fully established. The drug may be used when the potential benefit to the mother outweighs potential risks to the fetus or infant. Clinicians should discuss risks and benefits with the patient and consider alternative regimens when appropriate.
How do I order Lamivudina + Zidovudina Mylan from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does this product compare with other antiretroviral options?+
Zidovudine/lamivudine is a well‑established NRTI combination with a long safety record. Compared with newer agents, it may have a higher incidence of hematologic side effects but remains a cost‑effective option, especially in resource‑limited settings and when used in fixed‑dose combinations.
What are the storage and handling requirements for this medication?+
The product should be stored at ambient temperature, below 25 °C, in its original packaging. It must be kept away from moisture, excessive heat and direct sunlight to maintain stability and potency.
How is Lamivudina + Zidovudina Mylan administered?+
The medication is taken orally, usually with food or a glass of water to reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare provider and should not alter the regimen without medical advice.
What are the most serious risks associated with this therapy?+
Serious adverse events include severe anemia or neutropenia, lactic acidosis with hepatic steatosis, and hypersensitivity reactions such as rash or Stevens‑Johnson syndrome. Prompt medical evaluation is required if any of these symptoms develop.
Who should not use Lamivudina + Zidovudina Mylan?+
Patients with known hypersensitivity to zidovudine, lamivudine, or any excipients in the formulation should avoid the product. Caution is also advised for individuals with pre‑existing severe bone‑marrow suppression, hepatic impairment, or those receiving contraindicated drug combinations.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Viatris Limited
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU